Client
- Description
- Membership organization for plaintiffs' attorneys
- Location
- District of Columbia · United States of America
Registrant
- Firm
- ANDREW COCHRAN
- Description
- Government Relations
- Location
- Annandale, Virginia, United States of America
Lobbying activities
4 issuesCopyright/Patent/Trademark
H.R. 3309 (Innovation Act); to amend title 35, United States Code, and the Leahy-Smith America Invents Act to make improvements and technical corrections. General lobbying with regard to patent reform proposals, specific interest in proposals that would enact loser pays, mandatory sanctions, limits on discovery, fees on discovery or heightened pleading standards.
LobbyistsANDREW COCHRAN
Covered position (ANDREW COCHRAN): Senior Counsel, House Financial Services Committee
TargetedSENATE · HOUSE OF REPRESENTATIVES
Consumer Issues/Safety/Products
General lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. H.R.982 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. S.1009 (Chemical Safety Improvement Act of 2013); to improve the safety of consumers and modernize the Toxic Substances Control Act. General lobbying with regard to the ongoing development of a proposed TAFTA-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action.
LobbyistsANDREW COCHRAN
Covered position (ANDREW COCHRAN): Senior Counsel, House Financial Services Committee
